Basilea reports acceptance for regulatory review of Pfizer’s marketing authorization application for antifungal isavuconazole (Cresemba®) in invasive aspergillosis in China

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence